Is a change in voice, such as hoarseness, stridor, or throat tightness, an indication of anaphylaxis that requires epinephrine?

Yes, Voice Changes Are a Key Indicator of Anaphylaxis Requiring Immediate Epinephrine

Voice changes including hoarseness, throat tightness, and stridor are recognized respiratory manifestations of anaphylaxis and constitute an indication for immediate epinephrine administration. 1

Recognition of Voice Changes in Anaphylaxis

Voice changes represent upper airway involvement in anaphylaxis and include:

• Hoarseness (dysphonia) - occurs in up to 72.7% of certain presentations 2
• Throat tightness - one of the most common symptoms 1
• Stridor - indicates significant laryngeal edema 1
• Throat itching 1

These symptoms signal potentially life-threatening airway compromise and demand immediate action. The 2017 Pediatrics guidelines explicitly list "hoarseness, throat itching, throat tightness, stridor" as respiratory tract manifestations of anaphylaxis 1.

When to Administer Epinephrine

Epinephrine should be administered immediately when voice changes occur alongside:

1. Skin/mucosal involvement (urticaria, flushing, lip/tongue swelling) PLUS respiratory symptoms, OR
2. Two or more body systems affected after allergen exposure (skin, respiratory, cardiovascular, or GI symptoms) 1
3. Isolated severe respiratory symptoms with known allergen exposure 1

The 2024 AHA/Red Cross guidelines emphasize that epinephrine should be given "at the first sign of an anaphylactic reaction" 3. The FDA label for epinephrine specifically lists "airway swelling, laryngospasm, bronchospasm" as indications 4.

Critical Pitfall: Vocal Cord Dysfunction (VCD) Mimics Anaphylaxis

Important caveat: Voice changes can also result from vocal cord dysfunction/inducible laryngeal obstruction (VCD/ILO), which mimics anaphylaxis but does NOT respond to epinephrine 2, 5, 6.

Key distinguishing features of VCD versus anaphylaxis:

VCD characteristics:

• Predominant upper airway symptoms WITHOUT systemic involvement
• Dysphonia (72.7% vs 17.3% in anaphylaxis) 2
• Stridor (36.4% vs 1.9% in anaphylaxis) 2
• Absence of urticaria (18.2% vs 84.6% in anaphylaxis) 2
• Absence of cardiovascular symptoms (0% vs 55.8% in anaphylaxis) 2
• Multiple/chemical triggers rather than classic allergens 2
• Normal oxygen saturation despite respiratory distress 5
• Symptoms resistant to epinephrine 5

In the acute setting: If uncertain whether voice changes represent anaphylaxis or VCD, err on the side of treating as anaphylaxis with epinephrine 1. The risk of withholding epinephrine in true anaphylaxis (death) far exceeds the risk of giving it unnecessarily (transient tremor, anxiety, palpitations) 1.

Treatment Algorithm

1. Assess for anaphylaxis criteria - voice changes PLUS other system involvement
2. Administer epinephrine 0.3-0.5 mg IM (lateral thigh) immediately 3, 1, 7
3. Call 911/activate EMS 3
4. Position patient supine with legs elevated (unless respiratory distress worsens) 1
5. Prepare for second dose at 5-15 minutes if no improvement 3, 1, 3
6. Monitor closely - 7-18% require multiple epinephrine doses 3

Risk Factors for Severe Reactions

Patients with voice changes who also have these features are at higher risk for severe anaphylaxis requiring multiple epinephrine doses 8:

• Wheezing
• Cyanosis
• Hypotension/shock
• Stridor with laryngeal edema
• Arrhythmias
• Cough

Delayed epinephrine administration increases risk of hospitalization and death 1. Prompt prehospital epinephrine is associated with lower fatality rates 1.

Post-Treatment Considerations

After treating voice changes as anaphylaxis, if the patient has recurrent episodes resistant to epinephrine, consider referral to allergy/immunology for laryngoscopy to evaluate for VCD 2, 5, 9, 6. However, this evaluation should occur AFTER the acute episode, not during emergency management.